La Vanguardia, Cope, Revista Genética, among other media, have each published an article about the latest study led by ICREA researchers Salvador Aznar Benitah and Fran Supek. The study warns that special care should be taken regarding epigenetic therapies since although their anti-tumour effect may be beneficial initially, they can trigger the development of more aggressive tumours later on.
Link to La Vanguardia
La Razón and Info Diabético have each published an article about the work done by Manuel Serrano at IRB Barcelona: "If we eliminate damaged cells, the function of aged tissues is greatly improved, that is, they are rejuvenated," says Serrano, who goes on to point out that "it has been possible to delay and reverse the aging of small mammals, such as mice, with the use of experimental drugs that eliminate damaged cells."
Link to La Razón
Nació Digital has published an article about "Vi per Vida", an initiative promoted by the sommelier Xavier Ayala that aims to raise funds to support cancer research and metastasis at IRB Barcelona. The event will take place in Sant Sadurní d’Anoia on Sunday 2 December.
Link to Nacio Digital
TV3, RAC1, ABC, World Pharma News, Neuro Science, among other national and international media, have published articles about the research from the Peptides and Proteins Lab at IRB Barcelona. The study in question is inspired on the scorpion venom to deliver medicines to brain. The scientists have modified a peptide from the venom and used it as a shuttle to transport drugs across the barrier that protects the brain.
Link to TV3
Catalunya Ràdio interviewed Salvador Aznar Benitah, head of the Stem Cells and Cancer Lab at IRB Barcelona, and co-author of a recent study indicating that skin cells lose their identity over time and starts behaving like fat cells and thus do not exert their protective action.
Link to Catalunya Ràdio
El Punt Avui, La Vanguardia, Antena 3, EFE and El Diario Vasco, among other media, have published articles about the recent research led by IRB Barcelona and CNAG-CRG, which highlights that skin ages because its cells “forget” their function and stop secreting collagens and other proteins. The study has been published in the journal Cell and could have therapeutic applications aiming to help aged skin to form scar tissue faster and more efficiently after damage or after an operation.
Enlace a Antena 3
Muy Interesante, El Punt AVui, Diario Médico, Laboratory Journal and Federfarma, among other national and international media, have published articles about the research led by Núria López-Bigas, ICREA researcher at IRB Barcelona and that explains the origin of the mysterious periodicity in the genome.
Link to Muy Interesante
Link to Diario Médico
The “Dinero” supplement of the newspaper La Vanguardia has interviewed Roger Gomis, ICREA researcher at IRB Barcelona, about Inbiomotion, a spin-off from the institute and ICREA. This company, which came about from biomedical research and an entrepreneurial spirit, develops and commercialises a diagnostic test that allows the identification of those breast cancer patients most likely to develop bone metastasis. “It is very satisfying that an idea that arose in a lab has found a favourable environment in Barcelona in which to take a potentially life-saving product onto the market,” says Gomis.
The websites of Segre and Lleida have published an article on the latest Vi per Vida event, held last Sunday at "Les Obagues" ecocentre in Juneda. Organised by the sommelier Xavier Ayala and the Tastavins Juneda Association, this initiative aims to raise funds for cancer research and metastasis carried out at IRB Barcelona.
Link to Segre
Link to Lleida.com
The magazine Pharma Board Room has published an interview with Francesc Posas, director of IRB Barcelona, in which he explains the role of the institute as a bridge between basic research and specific treatments for patients: "IRB Barcelona is well positioned. Our exceptional faculty is producing some excellent science that will undoubtedly improve people's quality of life," said Posas.
Link to Pharma Board Room